• EN
Open Menu
  • HOME
  • SERVICES
  • WHO WE ARE
  • PARTNERSHIPS
  • RESOURCES
  • CAREER OPPORTUNITIES
  • CONTACT
  • HOME
  • SERVICES
  • WHO WE ARE
  • PARTNERSHIPS
  • RESOURCES
  • CAREER OPPORTUNITIES
  • CONTACT
You are here: Home > News > European Commission (EC) Decision Reliance Procedure (ECDRP)

European Commission (EC) Decision Reliance Procedure (ECDRP)

18 November 2022 – MHRA updated guidance on the EC decision reliance procedure.

On 30 September 2022 the ECDRP announced it will continue to be available until 31 December 2023, an extension of 12 months. Therefore the text “For a period of 2 years from 1 January 2021” was amended to “For a period of 3 years from 1 January 2023”.

Partnerships

-->
Contact

Widler & Schiemann AG can provide you with innovative, creative and cost effective answers to your questions and needs in the areas of Clinical Quality Management.

  • St Alban Ring 245, 4052 Basel, Switzerland
  • info@wsqms.com

Recent Facebook Posts
Most Popular
  • Project Leadership of Widler & Schiemann AG
  • Quality by Design
  • Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency Guidance for IRBs and Clinical Investigators
  • Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency
  • US FDA issues Institutional Review Board (IRB) Written Procedures
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /
  • Imprint
  • Facebook
  • Twitter
  • LinkedIn
  • Skype
  • Mail
  • Flickr